Search - tctmd.com

Displaying 521 - 537 of 537

Sort: Relevancy | Date

News Industry News

Novartis' new heart failure medicine LCZ696 approved by FDA to reduce risk of cardiovascular death and heart failure hospitalization; now called Entresto™ (sacubitril-valsartan)

July 07, 2015

News Industry News

Juventas Therapeutics Granted FDA Fast Track Designation and Phase 2b Protocol Allowance for Novel Heart Failure Gene Therapy

June 16, 2015

News Industry News

Juventas Therapeutics Presents New 12-Month Data Demonstrating Single Administration of JVS-100 Improves Cardiac and Clinical Status in Patients with Severe Ischemic Heart Failure One Year After Treat

May 26, 2015

News Industry News

CVRx® Barostim Therapy® for Heart Failure Clinical Trial Results Presented in the Late-Breaking Clinical Trial Session of the Heart Rhythm Society 2015 Annual Conference

May 26, 2015

News Daily News

Heart Failure Still a Problem but Less of a Burden on Acute MI Patients

Todd Neale

March 11, 2015

News Daily News

Many Heart Failure Patients Reap QoL Gain From TAVR Despite High Mortality

January 12, 2015

News Daily News

尽管死亡率高，但是许多心力衰竭患者接受TAVR后的生活质量提高

January 12, 2015

News Daily News

Muchos Pacientes con Insuficiencia Cardíaca Mejoran su Calidad de Vida Post-TAVR a pesar de la Alta Mortalidad descrita

January 12, 2015

Presentation TCT 2014

Midterm Results of a Novel Interatrial Shunt Therapy for Heart Failure and Preserved Ejection Fraction

Presenter: Finn Gustafsson

September 16, 2014

News Conference News ACC 2014

Intramyocardial Injection of Stem Cells Shows Promise for Severe Ischemic Heart Failure

Yael L. Maxwell

March 31, 2014

News Daily News

Meta-analysis: Heart Failure Worsens Short-term Prognosis of NSTE-ACS Patients

June 28, 2013

News Daily News

Shock-Wave Preconditioning Boosts Cell Therapy for Chronic Heart Failure

L.A. McKeown

April 19, 2013

News Conference News Cell Therapy 2013

Small Heart Failure Studies Show Positive Trends for Cell Therapy

January 27, 2013

Presentation TCT 2012

Transcatheter Interatrial Shunt for Heart Failure with Preserved Ejection Fraction (HFPEF)

Presenter: Brad Munt

October 22, 2012

News Daily News

CUPID: Gene Therapy Holds Promise in Heart Failure

July 12, 2011

News Conference News

STICH: CABG Does Not Extend Survival Over Medical Therapy in Heart Failure Patients

Caitlin E. Cox

April 04, 2011

Evaluating the Heart Failure Patient with MR: Integrating Train Data Into Clinical Practice

CME

Advertisement

Novartis' new heart failure medicine LCZ696 approved by FDA to reduce risk of cardiovascular death and heart failure hospitalization; now called Entresto™ (sacubitril-valsartan)

Juventas Therapeutics Granted FDA Fast Track Designation and Phase 2b Protocol Allowance for Novel Heart Failure Gene Therapy

Juventas Therapeutics Presents New 12-Month Data Demonstrating Single Administration of JVS-100 Improves Cardiac and Clinical Status in Patients with Severe Ischemic Heart Failure One Year After Treat

CVRx® Barostim Therapy® for Heart Failure Clinical Trial Results Presented in the Late-Breaking Clinical Trial Session of the Heart Rhythm Society 2015 Annual Conference

Heart Failure Still a Problem but Less of a Burden on Acute MI Patients

Many Heart Failure Patients Reap QoL Gain From TAVR Despite High Mortality

尽管死亡率高，但是许多心力衰竭患者接受TAVR后的生活质量提高

Muchos Pacientes con Insuficiencia Cardíaca Mejoran su Calidad de Vida Post-TAVR a pesar de la Alta Mortalidad descrita

Midterm Results of a Novel Interatrial Shunt Therapy for Heart Failure and Preserved Ejection Fraction

Intramyocardial Injection of Stem Cells Shows Promise for Severe Ischemic Heart Failure

Meta-analysis: Heart Failure Worsens Short-term Prognosis of NSTE-ACS Patients

Shock-Wave Preconditioning Boosts Cell Therapy for Chronic Heart Failure

Small Heart Failure Studies Show Positive Trends for Cell Therapy

Transcatheter Interatrial Shunt for Heart Failure with Preserved Ejection Fraction (HFPEF)

CUPID: Gene Therapy Holds Promise in Heart Failure

STICH: CABG Does Not Extend Survival Over Medical Therapy in Heart Failure Patients

Evaluating the Heart Failure Patient with MR: Integrating Data Into Clinical Practice

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content